Skip to main content
letter
. 2023 May 12;14:28. doi: 10.1186/s13293-023-00511-0

Fig. 1.

Fig. 1

Distribution of drug substances (n = 400) according to classification categories; No clinically relevant sex differences (A), Data on sex differences are lacking or where the data interpretation is complicated (B), Clinically relevant sex differences in some patient populations (C), Clinically relevant sex differences (C!)